OLUWATOBILOBA JEGEDE: Open Payments
NPI 1154772986 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 27 payments from 11 companies in 2025. Trend: 2023 $985 · 2024 $1,193 · 2025 $548
Food & beverage: $548
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 7 | $147 |
| Lundbeck LLC | 3 | $71 |
| ABBVIE INC. | 4 | $65 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| Janssen Pharmaceuticals, Inc | 2 | $49 |
| Noven Therapeutics, LLC | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| PFIZER INC. | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
Products named: Azstarys, REXULTI, VRAYLAR, COBENFY, SPRAVATO, Xelstrym, CAPLYTA, Auvelity.
Industry payments across CA — which companies pay providers there.
